Madison, Wisconsin, United States Wisconsin Alumni Research Foundation appeared to be the Corporate Investor, which was created in 1925. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Madison.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Wisconsin Alumni Research Foundation, startups are often financed by Venture Investors, Wisconsin Investment Partners, State of Wisconsin Investment Board. The meaningful sponsors for the fund in investment in the same round are State of Wisconsin Investment Board, Wisconsin Investment Partners, Venture Management. In the next rounds fund is usually obtained by Wisconsin Investment Partners, State of Wisconsin Investment Board, Venture Management.
The higher amount of exits for fund were in 2018. Speaking about the real fund results, this Corporate Investor is 8 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. This Wisconsin Alumni Research Foundation works on 8 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Energy Storage. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline FluGen, NeuWave Medical, Mithridion The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.
Related Funds
Funds with similar focus
| Fund Name | Location |
| EnergyAustralia | Australia, Melbourne, Victoria |
| Epsilon Health | - |
| Focus Investments | California, Encinitas, United States |
| Hitachi Data Systems | California, Santa Clara, United States |
| Long View Technology Ventures | Austin, Texas, United States |
| Naspers | Cape Town, South Africa, Western Cape |
| Swiggy | Bangalore, India, Karnataka |
| Ulrich Turck Family Office | - |
| Wuxi Jianfa | China, Jiangsu, Wuxi Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Leo Cancer Care | 11 Jun 2024 | Surrey, England, United Kingdom | |||
Ubicept | $8M | 25 Jul 2023 | Boston, Massachusetts, United States | ||
Realta Fusion | $9M | 31 May 2023 | Madison, Wisconsin, United States | ||
Pyran | $1M | 28 Feb 2023 | Madison, Wisconsin, United States | ||
Immuto Scientific | $2M | 08 Oct 2021 | Madison, Wisconsin, United States | ||
Pyran | $3M | 17 Aug 2021 | Madison, Wisconsin, United States | ||
Isomark | 16 Aug 2021 | Madison, Wisconsin, United States | |||
Leo Cancer Care | $25M | 20 Jul 2021 | Surrey, England, United Kingdom | ||
| $7M | 30 Apr 2021 | Madison, Wisconsin, United States |
– OnLume Surgical, a Madison, Wis.-based medical device company developing novel imaging systems for use during surgery, closed a $7m Series A funding.
– The round was led by Cambridge Investment Group (Luzich Partners LLC) with participation from WARF Ventures (Wisconsin Alumni Research Foundation) and Wisconsin Investment Partners (WIP).
– The company intends to use the funds to execute its plans for commercial launch.
– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Leo Cancer Care | 11 Jun 2024 | Surrey, England, United Kingdom | |||
Ubicept | $8M | 25 Jul 2023 | Boston, Massachusetts, United States | ||
Realta Fusion | $9M | 31 May 2023 | Madison, Wisconsin, United States | ||
Pyran | $1M | 28 Feb 2023 | Madison, Wisconsin, United States | ||
Immuto Scientific | $2M | 08 Oct 2021 | Madison, Wisconsin, United States | ||
Pyran | $3M | 17 Aug 2021 | Madison, Wisconsin, United States | ||
Isomark | 16 Aug 2021 | Madison, Wisconsin, United States | |||
Leo Cancer Care | $25M | 20 Jul 2021 | Surrey, England, United Kingdom | ||
| $7M | 30 Apr 2021 | Madison, Wisconsin, United States |
